Clinical Trial Update: To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing inhaled insulin to subcutaneous insulin in adults with Type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)
• Insulin (insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED